Viking Therapeutics Inc (NASDAQ: VKTX) on Monday, plunged -9.26% from the previous trading day, before settling in for the closing price of $35.42. Within the past 52 weeks, VKTX’s price has moved between $18.92 and $43.55.
Healthcare Sector giant saw their annual sales slid by -23.00% over the last five years. The company achieved an average annual earnings per share of -169.12%. With a float of $109.84 million, this company’s outstanding shares have now reached $112.45 million.
Viking Therapeutics Inc (VKTX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Viking Therapeutics Inc is 2.83%, while institutional ownership is 65.27%. The most recent insider transaction that took place on Jan 05 ’26, was worth 1,896,969. In this transaction Chief Financial Officer of this company sold 57,661 shares at a rate of $32.90, taking the stock ownership to the 189,891 shares. Before that another transaction happened on Jan 05 ’26, when Company’s Chief Operating Officer sold 57,661 for $32.98, making the entire transaction worth $1,901,405. This insider now owns 409,190 shares in total.
Viking Therapeutics Inc (VKTX) Recent Fiscal highlights
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Viking Therapeutics Inc (VKTX) is currently performing well based on its current performance indicators. A quick ratio of 28.34 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.12, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -3.75 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Analysing the last 5-days average volume posted by the [Viking Therapeutics Inc, VKTX], we can find that recorded value of 3.26 million was lower than the volume posted last year of 5.06 million. As of the previous 9 days, the stock’s Stochastic %D was 25.47%.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 45.47%, which indicates a significant increase from 4.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.54 in the past 14 days, which was lower than the 1.87 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.34, while its 200-day Moving Average is $30.47. Now, the first resistance to watch is $34.28. This is followed by the second major resistance level at $36.42. The third major resistance level sits at $37.64. If the price goes on to break the first support level at $30.92, it is likely to go to the next support level at $29.71. Now, if the price goes above the second support level, the third support stands at $27.57.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
Market capitalization of the company is 3.63 billion based on 113,036K outstanding shares. Right now, sales total 0 K and income totals -109,960 K. The company made 0 K in profit during its latest quarter, and -90,790 K in sales during its previous quarter.
